David Dobratz works in the field of Family Medicine. He attended University of Kansas School of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". David Dobratz is a published doctor as well. He has 1 publication published. The latest was: Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. David Dobratz accepts Medicare payments and is registered with Medicare.gov.
NPI NUMBER | 1245226166 | |
NPPES Provider LastName | DOBRATZ | |
NPPES Provider FirstName | DAVID | |
NPPES Provider ZIPCode | 662102761 | |
NPPES Provider State | KS | |
Specialty Description | Family Practice | |
Total Claim Count | 4478.0 | |
Distinct Opioid Count | 10.0 | |
Opioid Claim Count | 305.0 | |
Percent Opioid Claims | 6.81 |
National Provider Identifier [NPI] | 1245226166 |
Last Name Of The Provider | DOBRATZ |
First Name Of The Provider | DAVID |
View All |
Dr. David M. Riley, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Carol Feltheim, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Romeo M. Pineda Jr., MD | |
Dr. Suzan M. Lewis, DO
This Doctor is OpenDoctor Recommended. |
|
Dr. Catherine A. Post, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Michael A. Zybko, DO
This Doctor is OpenDoctor Recommended. |
|
Dr. William L. Coker, MD | |
Rebekah Robinson, NP |